Cornelis J.A. Punt

Medicine · Health Sciences

97h-index50.6kcitations706works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Colorectal Cancer Treatments and Studies(310), Genetic factors in colorectal cancer(148), Immunotherapy and Immune Responses(129), Gastric Cancer Management and Outcomes(107), Hepatocellular Carcinoma Treatment and Prognosis(102)

Publications705 total

Erratum: Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial
Journal of Clinical Oncology·2026
Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases
Annals of Surgical Oncology·2025
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database study
European Journal of Cancer·2025Open Access
816P Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastases
Annals of Oncology·2025
Total tumor volume predicts overall survival and response to induction chemotherapy in patients with colorectal cancer liver metastases: An ancillary study of the phase 3 CAIRO5 trial
European Journal of Cancer·2025Open Access
Morning administration of anthracyclines is associated with a lower risk of cancer therapy-related cardiac dysfunction
European Heart Journal Open·2025Open Access
Switch to oral S-1 in metastatic colorectal cancer patients with 5FU/capecitabine-induced cardiovascular toxicity
European Heart Journal Supplements·2025Open Access
113P Safety of adjuvant S-1 after capecitabine-induced toxicity in patients with colon cancer: A population-based real-world study
Annals of Oncology·2025Open Access
Perioperative systemic therapy for resectable colorectal peritoneal metastases: A multicenter randomized phase 3 trial (CAIRO6).
Journal of Clinical Oncology·2025· 4 cited
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases: individual patient data meta-analysis
British journal of surgery·2025· 2 citedOpen Access
Resectability assessment of colorectal liver metastases by an expert panel: Potential impact on hospitals referring patients for local treatment
European Journal of Surgical Oncology·2025Open Access
Longitudinal ctDNA measurements for treatment response monitoring in patients with metastatic colorectal cancer undergoing systemic therapy: The ORCA trial.
Journal of Clinical Oncology·2025
Total Tumor Volume Predicts Overall Survival and Response to Induction Chemotherapy in Patients with Colorectal Cancer Liver Metastases: An Ancillary Study of the Phase 3 Cairo5 Trial
SSRN Electronic Journal·2025Open Access
Prognostic value of radiologic and pathological response in colorectal cancer liver metastases upon systemic induction treatment: subgroup analysis of the CAIRO5 trial
ESMO Open·2024Open Access
Development and external evaluation of a self-learning auto-segmentation model for Colorectal Cancer Liver Metastases Assessment (COALA)
Insights into Imaging·2024· 5 citedOpen Access
First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases
JAMA Oncology·2024· 21 citedOpen Access
Feasibility and safety of single-fraction sub-ablative radiotherapy with systemic therapy in colorectal cancer patients with ≤ 10 metastases: A multicenter pilot study (NCT05375708)
Clinical and Translational Radiation Oncology·2024Open Access
High Prevalence of Chromosomal Rearrangements and LINE Retrotranspositions Detected in Formalin-Fixed, Paraffin-Embedded Colorectal Cancer Tissue
Journal of Molecular Diagnostics·2024Open Access
Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
JCO Clinical Cancer Informatics·2024· 6 citedOpen Access
Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group
Annals of Oncology·2024· 12 citedOpen Access
page 1 of 36Next →

Frequent Co-authors

Miriam Koopman(10), I. Jolanda M. de Vries(9), Carl G. Figdor(9), Eric Van Cutsem(7), J. Han van Krieken(7), Gosse J. Adema(7), Irıs D. Nagtegaal(7), W. Joost Lesterhuis(6), Thierry André(5), Geert-Jan Creemers(5), Annemieke Cats(5), Alexander M.M. Eggermont(5), Michel Ducreux(4), Wim J.G. Oyen(4), Takayuki Yoshino(4), Luis A. Díaz(4), Jolien Tol(4), Frans Erdkamp(4), Ninja Antonini(4), Linda Mol(4)